Icon

PURIXAN (nda205919)- (20MG/ML)

MERCAPTOPURINE NOVA LABS LTD
20MG/ML
No Yes
Expired Expired
2021-Apr-28 None
None No
PURIXAN is a nucleoside metabolic inhibitor indicated for the treatment of patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen.
0 0 0
Total Other Developers 2
Drugs with Suitability No
20MG/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.